Importance and Relevance of Pulmonary Symptoms Among Patients Receiving Second- and Third-Line Treatment for Advanced Non–Small-Cell Lung Cancer: Support for the Content Validity of the 4-Item Pulmonary Symptom Index-Reference-Cited by-同舟云学术

Importance and Relevance of Pulmonary Symptoms Among Patients Receiving Second- and Third-Line Treatment for Advanced Non–Small-Cell Lung Cancer: Support for the Content Validity of the 4-Item Pulmonary Symptom Index

Published:2013-05 Issue:3 Volume:14 Page:245-253
ISSN:1525-7304
Container-title:Clinical Lung Cancer
language:en
Short-container-title:Clinical Lung Cancer

Author:

Magasi Susan,Mallick Rajiv,Kaiser Karen,Patel Jyoti D.,Lad Thomas,Johnson Melissa L.,Kaplan Edward H.,Cella David

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference58 articles.

1. Cancer facts and figures 2012,2012

2. Cancer statistics;Siegel;CA Cancer J Clin,2012

3. Lung cancer (non-small cell),2012

4. Ten-year survey of lung cancer treatment and survival in hospitals in the United States: a national cancer data base report;Fry;Cancer,1999

5. Management issues for stage IV non-small cell lung cancer;Earle;Cancer Control,1997

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Content validation of the National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy Lymphoma Symptom Index-18 (NFLymSI-18) in indolent B-cell non-Hodgkin’s lymphoma;Journal of Patient-Reported Outcomes;2024-07-09

2. Intensifying treatment in PET-positive multiple myeloma patients after upfront autologous stem cell transplantation;Leukemia;2023-08-11

3. Identifying symptomatic adverse events using the patient‐reported outcomes version of the common terminology criteria for adverse events in patients with non‐small cell lung cancer with epidermal growth factor receptor exon 20 insertion mutations;Cancer Medicine;2022-12-30

4. Development of the Functional Assessment of Cancer Therapy-Carcinoid Syndrome Symptom Index;Neuroendocrinology;2020-09-10

Assessing Preferences for Rare Disease Treatment: Qualitative Development of the Paroxysmal Nocturnal Hemoglobinuria Patient Preference Questionnaire (PNH-PPQ©)

;Patient Preference and Adherence;2020-04